Cargando…
COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome
This is a brief report of a patient who has refractory Myasthenia Gravis, on multiple long-term immunosuppressive therapies and contracted COVID-19 during this 2020 pandemic. She was quarantined for total of 14 days and recovered successfully without any complications (no myasthenia exacerbation or...
Autores principales: | Ramaswamy, Swathi Beladakere, Govindarajan, Raghav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369032/ https://www.ncbi.nlm.nih.gov/pubmed/32508329 http://dx.doi.org/10.3233/JND-200520 |
Ejemplares similares
-
A case report of COVID-19 in refractory myasthenia: Outcome with remdesivir and dexamethasone
por: Bhagavan, Sachin M., et al.
Publicado: (2021) -
Recurrent Opportunistic Infections in a Thymectomised Patient with Myasthenia Gravis and Good’s Syndrome
por: Shankar Kikkeri, Nidhi, et al.
Publicado: (2018) -
COVID-19 and generalized Myasthenia Gravis exacerbation: A case report
por: Singh, Shivangi, et al.
Publicado: (2020) -
Brachial plexopathy with Sjögren syndrome
por: Bhagavan, Sachin M., et al.
Publicado: (2019) -
Clinical Experience with Eculizumab in Treatment-Refractory Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis
por: Katyal, Nakul, et al.
Publicado: (2021)